Disclaimer: That Intended For Medical Professionals Only
AjantaMed Dialogue
Stay Informed, Stay Ahead
Latest News :
New Heart Health Study Shows Positive Results PharmaCare Launches New Immunity Formula Quality Healthcare Products Breakthrough Announced in Pain Management New Heart Health Study Shows Positive Results PharmaCare Launches New Immunity Formula Quality Healthcare Products Breakthrough Announced in Pain Management
sticky-medbot
ROBUST Study Nonauthor Collaborators – JAPI Cardiology

ROBUST Study Nonauthor Collaborators – JAPI

Tue Feb 03 2026 Trasha 1 min read 16 Views

A cross-sectional survey was conducted among 1,000 Indian HCPs, including consulting physicians, cardiologists, and specialists in diabetes/metabolism experienced in managing adult patients across the HTN and CV disease continuum. Responses from 855 HCPs were analyzed. Consulting physicians (431; 50.4%) and cardiologists (342; 40.0%) formed the majority. This survey highlights real-world prescribing patterns and perceptions of β-blockers in India.

 

The attached PDF provides the list of participating doctors involved in this survey.

More Related Blogs

Subscribe to our newsletter

Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.